Arovella Therapeutics (ASX:ALA) has successfully manufactured and passed quality release testing for its lead product ALA-101 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20240102/pdf/05z33l2t26k412.pdf #ALA #Cancer
ASR
0.002
100%
MHK
0.17
-54.1%
WEL
0.002
100%
XPN
0.007
-36.4%
ALM
0.006
50%
ECT
0.002
-33.3%
DMG
0.006
50%
AQC
0.009
-25%
I88
0.17
36%
CHM
0.003
-25%
CR9
0.004
33.3%
CTT
0.26
-23.5%
MSG
0.008
33.3%
3DP
0.046
-19.3%
TOU
0.024
33.3%
GRE
0.065
-18.8%
DDT
0.005
25%
IR1
0.09
-18.2%
OEL
0.005
25%
RR1
0.009
-18.2%
SRL
1.31
24.8%
BNL
0.005
-16.7%
BDG
0.086
22.9%
NOX
0.105
-16%
IS3
0.011
22.2%
MQR
0.011
-15.4%
IAM
0.035
20.7%
LM1
0.098
-14.8%
FAU
0.006
20%
LU7
0.006
-14.3%
FBR
0.006
20%
M4M
0.006
-14.3%
VEN
0.006
20%
SER
0.006
-14.3%
BCA
0.322
19.3%
IG6
0.061
-14.1%
WBT
2.42
19.2%
AGR
0.025
-13.8%
NHE
0.05
19%
MAG
0.044
-13.7%
